Clinical Outcomes of Pessary Use in Pelvic Organ Prolapse in the Institute of Applied Health Sciences Under Prosanti Project

Background: Pelvic Organ Prolapse (POP) accounts for a large proportion of women's referrals and is a phenomenon particularly associated with multiparous and postmenopausal women. The symptoms of POP are mainly vaginal bulge, pelvic pressure, urinary and/or bowel complaints. Vaginal pessaries are the most frequently used first-line conservative treatment choice that can alleviate symptoms without surgery. The main purpose of this research was to assess the clinical outcomes, side effects and patient satisfaction with pessary treatment in patients with POP at the Institute of Applied Health Sciences (IAHS) under the Prosanti project. Materials and methods: This prospective observational study was conducted at the Institute of Applied Health Sciences (IAHS) from January 2025 to December 2025 and included 68 women diagnosed with symptomatic pelvic organ prolapse. Data were entered and analyzed using SPSS version 26.0. Results: Uterovaginal prolapse (44.1%) and Stage III prolapse (52.9%) were the leading conditions, with the majority of patients (94.1%) reporting vaginal bulge. Ring pessaries were the predominant choice (64.7%), with initial fitting success in 85.3% of cases. At 6 months, 88.2% of the patients' vaginal bulge had resolved, 85.7% of their urinary symptoms improved, 66.7% of their bowel symptoms improved and overall symptom relief was 85.3%. Retention of pessary use was 79.4%, and only minor issues such as vaginal discharge (20.6%) and expulsion of the device (11.8%) were noticed. General satisfaction was quite high at 79.4% and there were no reports of serious adverse events. Conclusion: Vaginal pessaries at IAHS were a conservative treatment that proved to be effective and safe for pelvic organ prolapse. Most patients were successfully fitted (85.3%) and showed significant symptom relief, especially their symptoms of vaginal bulge and urinary complaints, an improvement rate of 85.3% in total. The 6, month continuation rate reached 79.4%, the complications were mostly minor, and the overall satisfaction was high (79.4%). IAHS Medical Journal Vol 9(1), June 2026; 26-30